| Bioactivity | EGFRvIII peptide is a EGFRvIII derived epitope for binding to MHC I molecules. EGFRvIII peptide induces apoptosis, causes specific immune responses against glioblastoma, especially in combination of Flagellin B[1]. |
| CAS | 916850-24-3 |
| Sequence | Leu-Glu-Glu-Lys-Lys-Gly-Asn-Tyr-Val |
| Shortening | LEEKKGNYV |
| Formula | C48H78N12O16 |
| Molar Mass | 1079.20 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Choi JM, et al., Flagellin synergistically enhances anti-tumor effect of EGFRvIII peptide in a glioblastoma-bearing mouse brain tumor model. BMC Cancer. 2022 Sep 15;22(1):986. |
EGFRvIII peptide
CAS: 916850-24-3 F: C48H78N12O16 W: 1079.20
EGFRvIII peptide is a EGFRvIII derived epitope for binding to MHC I molecules. EGFRvIII peptide induces apoptosis, cause
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.